SMITH+NEPHEW ADR5 DL-20/2
SMITH+NEPHEW ADR5 DL-20/2
Certificado de depósito · US83175M2052 · SNN · 939163 (XNYS)
Resumen
30,27 USD
-0,13 % -0,04 USD
NYSE (XNYS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 19:59

Cotizaciones actuales de SMITH+NEPHEW ADR5 DL-20/2

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNYS: NYSE
NYSE
SNN
USD
06.06.2025 19:59
30,27 USD
30,31 USD
-0,13 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % 4,56 % 6,89 % 1,58 % 19,31 % 14,92 % -31,58 %

Perfil de la empresa para SMITH+NEPHEW ADR5 DL-20/2 Certificado de depósito

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Datos de la empresa

Nombre SMITH+NEPHEW ADR5 DL-20/2
Empresa Smith & Nephew plc
Símbolo SNN
Sitio web https://www.smith-nephew.com
Mercado principal XNYS NYSE
WKN 939163
ISIN US83175M2052
Tipo de valor Certificado de depósito
Sector Healthcare
Industria Medical - Devices
CEO Dr. Deepak S. Nath Ph.D.
Capitalización de mercado 11 Mrd.
País Reino Unido
Moneda USD
Empleados 17,3 T
Dirección Building 5, WD18 8YE Watford
Fecha de OPV 1999-11-16

Splits de acciones

Fecha Split
15.10.2014 2499:1000
16.12.2003 2:1
07.08.2000 9:11

Símbolos de cotización

Nombre Símbolo
Frankfurt NPWA.F
NYSE SNN

Otras acciones

Los inversores que tienen SMITH+NEPHEW ADR5 DL-20/2 también tienen las siguientes acciones en su cartera:
AEGON 09/39 MTN
AEGON 09/39 MTN Bono
JYSKE BANK 21/UND. FLRMTN
JYSKE BANK 21/UND. FLRMTN Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025